Terminated OBSERVATIONAL NCT05985291

BurstDR Stimulation for Painful Diabetic Neuropathy

BurstDRTM Spinal Cord Dorsal Column Stimulation for Painful Diabetic Neuropathy

Sponsor: Wake Forest University Health Sciences

Interventions SCS in combination with CMM

Updated 7 times since 2023 Last updated: Nov 4, 2025 Started: Jul 3, 2023 Primary completion: Oct 6, 2025 Completion: Oct 6, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Principal Investigator left Advocate Health

Other terminated trials from Wake Forest University Health Sciences

See all terminations from Wake Forest University Health Sciences

This observational or N/A phase trial investigates Painful Diabetic Neuropathy and is currently terminated or withdrawn. Wake Forest University Health Sciences leads this study, which shows 7 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Dec 2025 — Present [monthly]

Terminated

Status: Recruiting → Terminated
Nov 2025 — Dec 2025 [monthly]

Recruiting
Dec 2024 — Nov 2025 [monthly]

Recruiting
Nov 2024 — Dec 2024 [monthly]

Recruiting
Sep 2024 — Nov 2024 [monthly]

Recruiting

▶ Show 2 earlier versions

Jul 2024 — Sep 2024 [monthly]

Recruiting
Sep 2023 — Jul 2024 [monthly]

Recruiting

First recorded

Jul 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Wake Forest University Health Sciences

Data source: Wake Forest University Health Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oshkosh, United States